Interobserver variability in identification of breast tumors in MRI and its implications for prognostic biomarkers and radiogenomics.
暂无分享,去创建一个
Maciej A Mazurowski | Lars J. Grimm | Ashirbani Saha | Michael R. Harowicz | Sujata V Ghate | Connie E. Kim | Ruth Walsh | Lars J Grimm | M. Mazurowski | Ashirbani Saha | S. Ghate | R. Walsh | Connie Kim | Michael Harowicz
[1] Woo Kyung Moon,et al. Early Prediction of Response to Neoadjuvant Chemotherapy Using Parametric Response , 2015 .
[2] B. Pogue,et al. Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes. , 2009, Radiology.
[3] L. Esserman,et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. , 2005, AJR. American journal of roentgenology.
[4] Bonnie N Joe,et al. Breast MR imaging for extent of disease assessment in patients with newly diagnosed breast cancer. , 2013, Magnetic resonance imaging clinics of North America.
[5] L. Turnbull,et al. Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy. , 2009, European journal of radiology.
[6] Michael D. Feldman,et al. Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for Classifying Breast Cancer Recurrence Risk , 2015, IEEE Transactions on Biomedical Engineering.
[7] M. Giger,et al. Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers. , 2010, Radiology.
[8] Maciej A Mazurowski,et al. Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. , 2014, Radiology.
[9] Andreas Makris,et al. Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer , 2008, Clinical Cancer Research.
[10] Kenneth G A Gilhuijs,et al. Current clinical indications for magnetic resonance imaging of the breast , 2014, Journal of surgical oncology.
[11] Harini Veeraraghavan,et al. Breast cancer molecular subtype classifier that incorporates MRI features , 2016, Journal of magnetic resonance imaging : JMRI.
[12] L. Schwartz,et al. Malignant lesion segmentation in contrast-enhanced breast MR images based on the marker-controlled watershed. , 2009, Medical physics.
[13] Hon J. Yu,et al. Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. , 2008, Academic radiology.
[14] John Kornak,et al. Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes , 2016, PloS one.
[15] Kyung Hee Ko,et al. Mammography, US, and MRI for Preoperative Prediction of Extensive Intraductal Component of Invasive Breast Cancer: Interobserver Variability and Performances. , 2016, Clinical breast cancer.
[16] Woo Kyung Moon,et al. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI , 2013, Acta radiologica.
[17] Jung Hyun Yoon,et al. Breast parenchymal signal enhancement ratio at preoperative magnetic resonance imaging: association with early recurrence in triple-negative breast cancer patients , 2016, Acta radiologica.
[18] A. Madabhushi,et al. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study. , 2014, Radiology.
[19] R. A. Lerski,et al. Magnetic resonance imaging texture analysis classification of primary breast cancer , 2016, European Radiology.
[20] Maryellen L. Giger,et al. A Fuzzy C-Means (FCM)-Based Approach for Computerized Segmentation of Breast Lesions in Dynamic Contrast-Enhanced MR Images1 , 2006 .
[21] L. Costaridou,et al. Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis. , 2010, The British journal of radiology.
[22] H. Lehr,et al. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. , 2006, Radiology.
[23] A Horsman,et al. Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. , 1997, The British journal of radiology.
[24] Maciej A Mazurowski,et al. Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer? , 2017, Journal of magnetic resonance imaging : JMRI.
[25] Wei Tse Yang,et al. Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression Profiles , 2015 .
[26] Maryellen L. Giger,et al. Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data , 2015, Journal of medical imaging.
[27] Maciej A Mazurowski,et al. Recurrence-free survival in breast cancer is associated with MRI tumor enhancement dynamics quantified using computer algorithms. , 2015, European journal of radiology.
[28] Wei Huang,et al. A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings. , 2012, Magnetic resonance imaging.
[29] Roberto Orecchia,et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. , 2010, European journal of cancer.
[30] Lihua Li,et al. A new quantitative image analysis method for improving breast cancer diagnosis using DCE-MRI examinations. , 2014, Medical physics.
[31] T. Helbich,et al. Breast MRI: EUSOBI recommendations for women’s information , 2015, European Radiology.
[32] L. Turnbull,et al. Dynamic contrast‐enhanced MRI in the differentiation of breast tumors: User‐defined versus semi‐automated region‐of‐interest analysis , 1999, Journal of magnetic resonance imaging : JMRI.
[33] Mark Rosen,et al. A Multichannel Markov Random Field Framework for Tumor Segmentation With an Application to Classification of Gene Expression-Based Breast Cancer Recurrence Risk , 2013, IEEE Transactions on Medical Imaging.
[34] W. Kaiser,et al. Lesion type and reader experience affect the diagnostic accuracy of breast MRI: a multiple reader ROC study. , 2015, European journal of radiology.
[35] G. Newstead,et al. Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer , 2015, Breast Cancer.
[36] Ahmed Bilal Ashraf,et al. Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles. , 2014, Radiology.
[37] Lars J. Grimm,et al. Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms , 2015, Journal of magnetic resonance imaging : JMRI.